Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Veterinary Infusion Pumps Market: Smart Infusion System Adoption and Companion Animal Critical Care Expansion to Drive Market Growth

The global Veterinary Infusion Pumps market was valued at USD 298.7 million in 2025 and is projected to reach USD 592.1 million by 2035, expanding at a CAGR of 7.9%. The market encompasses volumetric infusion pumps (peristaltic, linear, multi-channel, portable), syringe infusion pumps (single, dual, and multi-syringe), ambulatory infusion pumps (wearable, battery-operated), and the accessories and consumables consumed per infusion episode (infusion sets, IV tubing, catheters, pump batteries). Infusion pumps are deployed across companion animal veterinary hospitals and ICUs, equine infusion therapy, livestock production critical care, and companion animal home fluid therapy settings.

The market is growing at a 7.9% CAGR driven by the expansion of companion animal 24/7 emergency and critical care hospitals — each requiring multiple-channel ICU infusion pump suites — and by the transition from conventional infusion pumps to smart infusion systems with dose-error reduction drug libraries, weight-based dosing calculators, and wireless hospital information system integration. Each new 24/7 companion animal emergency hospital installation represents USD 30,000–150,000 in ICU infusion pump capital investment. Constant rate infusion (CRI) of opioids, ketamine, dexmedetomidine, and lidocaine for companion animal post-operative and ICU pain management has become the standard of care at specialist hospitals, sustaining multi-channel syringe pump utilisation at each critically ill companion animal ICU hospitalisation.

Executive Snapshot

What is the confirmed 2025 market size and projected 2035 value for the veterinary infusion pumps market?
The market was valued at USD 298.7 million in 2025 and is projected to reach USD 592.1 million by 2035 at a 7.9% CAGR. Volumetric infusion pumps are the dominant product type by revenue. Syringe infusion pumps are the highest-unit-volume product. Smart infusion pumps are the fastest-growing product category. Companion animals are the dominant species segment. Veterinary hospitals and ICU settings are the primary end-users. North America leads; Asia-Pacific grows fastest from 24/7 emergency hospital development.

How does 24/7 companion animal emergency hospital expansion drive infusion pump capital installation demand?
Board-certified ACVECC veterinary emergency and critical care specialists defining mechanical IV infusion as standard of care for companion animal ICU fluid therapy, vasopressor support (dopamine, norepinephrine), constant rate infusion (CRI) analgesia, and oncology chemotherapy delivery require multiple simultaneous infusion channels per ICU patient. Each new 24/7 companion animal emergency hospital deploys 6–12 volumetric and syringe pump stations per ICU bed capacity, representing USD 30,000–150,000 in infusion pump capital investment per new hospital facility. Corporate 24/7 emergency hospital network expansion (BluePearl Emergency, Ethos Emergency) is the primary infusion pump market growth driver.

What drives smart infusion pump adoption above conventional volumetric pump replacement?
Smart infusion pumps — with drug-specific dose libraries, weight-based dosing calculators (mg/kg/hour auto-calculation), maximum dose guardrails, and wireless integration with veterinary hospital information systems — are growing from companion animal specialist hospital adoption of human-equivalent medication safety standards. Drug library guardrails preventing inadvertent 10-fold dosing errors are particularly critical in companion animal critical care where species-specific pharmacokinetics and weight-based dosing variation create high medication error risk with conventional manually-programmed pumps. Each smart pump installation sustains annual drug library update subscription revenue above the capital equipment purchase.

How does companion animal oncology chemotherapy administration sustain syringe pump ICU demand?
Companion animal lymphoma, mast cell tumour, and solid tumour chemotherapy protocols (CHOP, vincristine, doxorubicin, carboplatin, lomustine) require precision IV infusion pump administration at defined infusion rates — typically 30–90 minute slow IV infusions requiring controlled volumetric delivery with defined maximum rate guardrails to prevent rapid infusion toxicity. Companion animal oncology case volumes are growing from cancer screening platform adoption identifying lymphoma and cancer patients, sustaining syringe pump demand at companion animal oncology specialist hospitals and university veterinary oncology services.

What drives companion animal home infusion pump adoption as a growing channel?
Feline chronic kidney disease (CKD) — the most common companion animal systemic disease in cats above age 10, affecting approximately 30–40% of senior cats — is managed with subcutaneous fluid therapy (lactated Ringer’s solution or 0.9% NaCl) 2–3 times weekly at home in compliant owner households. Ambulatory infusion pump availability for feline home subcutaneous fluid therapy reduces owner dexterity barriers compared to manual subcutaneous injection techniques. Companion animal home chemotherapy protocols requiring ambulatory pump delivery represent an emerging home infusion channel above conventional home fluid therapy.

Which regional markets are growing fastest for veterinary infusion pumps?
Asia-Pacific is the fastest-growing regional veterinary infusion pump market from 24/7 companion animal emergency and critical care hospital development in China, South Korea, and Japan — where corporate companion animal hospital chains are investing in ICU critical care capability including multi-channel infusion pump suites. The large companion animal patient population and growing ICU critical care service demand in urban Asian markets sustain above-global-average Asia-Pacific infusion pump market growth from a low ICU hospital density baseline.

Request Sample
Speak with an Analyst
Download TOC

Market Dynamics: Veterinary Infusion Pumps Market

  • 24/7 companion animal emergency hospital expansion creating ICU infusion pump capital installation demand at each new facility. Corporate 24/7 emergency hospital development deploying 6–12 infusion pump stations per ICU bed capacity — sustaining infusion pump capital demand from new hospital facility installations above existing hospital replacement cycles.
  • Smart infusion pump adoption from companion animal hospital medication safety standard elevation above conventional manually-programmed pump baseline. Drug library, weight-based dosing calculator, and guardrail smart pump adoption from companion animal specialist hospital medication safety standards — creating recurring drug library update subscription revenue above hardware capital.
  • CRI analgesic protocol adoption — opioid, ketamine, dexmedetomidine, lidocaine — as ICU and post-operative companion animal pain management standard of care. Multi-channel CRI analgesia delivery sustaining multi-channel syringe pump utilisation at each companion animal ICU and post-operative hospitalisation — growing from ACVECC and ACVAA analgesic protocol standard of care adoption.
  • Companion animal oncology chemotherapy case volume growth sustaining precision IV syringe pump demand at oncology specialist hospitals. Growing companion animal lymphoma and cancer chemotherapy case volumes — driven by cancer screening patient identification — sustaining precision syringe pump demand for controlled IV chemotherapy infusion at oncology specialist centres.
  • Feline CKD home subcutaneous fluid therapy ambulatory pump adoption growing from owner compliance and dexterity improvement above manual injection. Ambulatory subcutaneous fluid therapy pumps enabling feline CKD home management with reduced owner dexterity barrier — growing the home infusion pump channel above conventional hospital-only infusion pump deployment.
  • Asia-Pacific 24/7 companion animal emergency hospital investment driving infusion pump capital demand from a low ICU hospital density baseline. Corporate companion animal emergency hospital development in China, South Korea, and Japan deploying ICU infusion pump suites — sustaining above-global-average Asia-Pacific infusion pump market growth from the rapidly growing 24/7 emergency hospital base.

Market Segmentation: Veterinary Infusion Pumps Market

By Route of Administration
  • Intravenous (IV)
  • Subcutaneous
  • Epidural Infusion
  • Intraosseous
  • Intraperitoneal
  • Enteral Feeding
  • Other Routes of Administration
By Application
  • Fluid Therapy
  • Anesthesia
  • Pain Management
  • Nutritional Support
  • Chemotherapy
  • Blood & Blood Product Transfusion
  • Critical Care
  • Emergency Medicine
  • Intensive Care
  • Other Applications
By Technology
  • Conventional Infusion Pumps
  • Smart Infusion Pumps
  • Programmable Infusion Pumps
  • Wireless/Connected Infusion Pumps
  • AI-Enabled Infusion Pumps
By Mobility
  • Stationary Infusion Pumps
  • Portable Infusion Pumps
  • Ambulatory Infusion Pumps
By Product Type
  • Volumetric Infusion Pumps
    • Peristaltic Infusion Pumps
    • Linear Infusion Pumps
    • Multi-Channel Infusion Pumps
    • Portable Volumetric Infusion Pumps
  • Syringe Infusion Pumps
    • Single Syringe Pumps
    • Dual Syringe Pumps
    • Multi-Syringe Pumps
  • Ambulatory Infusion Pumps
    • Wearable Infusion Pumps
    • Portable Battery-Operated Pumps
  • Accessories & Consumables
    • Infusion Sets
    • Syringes
    • Extension Sets
    • IV Tubing
    • Catheters
    • Pump Batteries
    • Other Accessories & Consumables
By Animal Type
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Birds
    • Rabbits
    • Exotic Pets
    • Other Companion Animals
  • Livestock Animals
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Fish (Aquaculture)
    • Other Livestock Animals
By Distribution Channel
  • Direct Sales
  • Veterinary Equipment Distributors
  • E-Commerce
  • Veterinary Supply Stores
  • Other Distribution Channels
By End User
  • Veterinary Hospitals & Clinics
  • Home Care
  • Research & Academic Institutions
  • Veterinary Specialty Centers
  • Animal Shelters & Rescue Centers
  • Livestock Farms
  • Other End Users
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Veterinary Infusion Pumps Market

  1. 24/7 companion animal emergency and critical care hospital expansion creating ICU infusion pump suite capital installation demand at each new facility. Corporate 24/7 emergency hospital development — ACVECC specialist-staffed ICU deploying 6–12 infusion pump stations per bed capacity — sustaining infusion pump capital demand from the expanding emergency hospital network.
  2. Smart infusion pump adoption from medication safety drug library and weight-based dosing guardrail standard elevation at companion animal specialist hospitals. Smart pump drug library and guardrail adoption from companion animal ICU medication safety standards — creating recurring subscription revenue above hardware and improving dosing safety above manually-programmed conventional pumps.
  3. CRI multi-channel analgesic protocol adoption as companion animal ICU and post-operative pain management standard of care. Multi-channel CRI opioid, ketamine, and dexmedetomidine infusion sustaining multi-syringe pump demand at each companion animal ICU hospitalisation from ACVECC and ACVAA standard of care adoption.
  4. Companion animal oncology chemotherapy precision IV administration sustaining syringe pump demand at oncology specialist centres. Growing companion animal cancer case volumes requiring precision slow IV chemotherapy infusion — sustaining controlled syringe pump demand at oncology specialist hospitals and university veterinary oncology services.
  5. Feline CKD home subcutaneous fluid therapy ambulatory pump adoption growing from owner compliance and dexterity improvement. Ambulatory subcutaneous fluid pumps enabling feline CKD home management with reduced owner barrier — growing the home infusion channel above hospital-only pump deployment.
  6. Asia-Pacific 24/7 emergency hospital development driving ICU infusion pump capital demand from a low emergency hospital density baseline. Corporate companion animal emergency hospital expansion in China, South Korea, and Japan deploying ICU infusion pump infrastructure — sustaining above-global-average Asia-Pacific market growth.

Regional Outlook: Veterinary Infusion Pumps Market

  • North America: Largest regional veterinary infusion pump market, anchored by the highest 24/7 companion animal emergency hospital density globally, the most advanced ACVECC board-certified critical care specialist deployment, and the most complete smart infusion pump adoption across companion animal ICU facilities. The U.S. leads in CRI analgesic protocol standard of care adoption and companion animal oncology chemotherapy infusion pump utilisation.
  • Europe: Significant and established market with strong companion animal emergency and critical care hospital infrastructure across the UK, Netherlands, France, and Germany. European veterinary emergency and critical care specialist training (ECC residency programmes) is growing the specialist infusion pump-deploying hospital base. Smart infusion pump adoption is advancing from European companion animal hospital patient safety standard elevation.
  • Asia-Pacific: Fastest-growing regional infusion pump market from 24/7 companion animal emergency and critical care hospital development in China, South Korea, and Japan — where corporate companion animal hospital chains are investing in ICU critical care capability including multi-channel smart infusion pump suites. The low current emergency hospital density and rapidly growing companion animal healthcare demand sustain above-global-average Asia-Pacific infusion pump market growth.

Competitive Landscape: Veterinary Infusion Pumps Market

Key Players: B. Braun Melsungen AG, ICU Medical (Smith’s Medical), Mila International, Helixx Group (VetPump), Mindray Medical International, Baxter International, Covetrus (Infusion Supply Distribution), Jorgensen Laboratories, Vetivio (Veterinary Smart Infusion), and Dunlimed (Veterinary Infusion Pumps)

Recent Developments

  • Braun Melsungen AG confirmed in its FY2024 Annual Report that its Infusion Therapy division — encompassing volumetric infusion pumps, syringe pumps, and IV administration set accessories — serves veterinary hospital and ICU settings alongside human clinical applications, with B. Braun Perfusor and Infusomat infusion pump systems widely deployed in companion animal critical care and anaesthesia settings as the primary fluid therapy and CRI analgesic infusion delivery platform at companion animal specialist and emergency hospitals globally.
  • ICU Medical confirmed in its FY2024 Annual Report the commercial availability of its Plum 360 and SIGMA Spectrum smart infusion systems — with drug library dose-error reduction software and weight-based dosing guardrails — that are deployed at companion animal specialist hospitals adopting human-equivalent medication safety standards for ICU fluid therapy, CRI analgesic infusion, and oncology chemotherapy delivery, with drug library subscription revenue creating recurring income above one-time infusion pump hardware capital purchase.
  • Helixx Group confirmed the commercial availability of its VetPump veterinary-specific syringe pump platform — designed for companion animal CRI applications including opioid analgesia, ketamine infusion, dexmedetomidine sedation, and oncology chemotherapy administration — with integrated weight-based dose calculator functionality reducing manual dose computation error risk in companion animal ICU and post-operative pain management settings at companion animal specialist hospitals across North America.

Consultant POV

The Veterinary Infusion Pumps market’s 7.9% CAGR to USD 592.1 million by 2035 is anchored in the structural expansion of companion animal 24/7 emergency and critical care hospital infrastructure — with each new ICU facility requiring multi-channel smart infusion pump investment — and the CRI analgesic protocol standard of care adoption sustaining continuous syringe pump utilisation per critically ill companion animal hospitalisation. B. Braun‘s veterinary Perfusor installed base, ICU Medical‘s smart pump drug library platform, and Helixx‘s veterinary-specific VetPump confirm that the infusion pump market will sustain above-medical-device-sector-average growth through 2035 as companion animal critical care standards converge toward human-equivalent ICU infusion precision and safety.

Request Sample
Speak with an Analyst
Download TOC

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

More Press Releases

Speak with an Analyst

    Download TOC

      Request a Sample Report